Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 337


Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes.

Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S.

Circulation. 2010 Feb 16;121(6):750-8. doi: 10.1161/CIRCULATIONAHA.109.891523. Epub 2010 Feb 1.


The relationship between adherence to the Mediterranean diet and the severity and short-term prognosis of acute coronary syndromes (ACS): The Greek Study of ACS (The GREECS).

Panagiotakos DB, Arapi S, Pitsavos C, Antonoulas A, Mantas Y, Zombolos S, Stefanadis C.

Nutrition. 2006 Jul-Aug;22(7-8):722-30. Epub 2006 May 30.


Physical activity status and acute coronary syndromes survival The GREECS (Greek Study of Acute Coronary Syndromes) study.

Pitsavos C, Kavouras SA, Panagiotakos DB, Arapi S, Anastasiou CA, Zombolos S, Stravopodis P, Mantas Y, Kogias Y, Antonoulas A, Stefanadis C; GREECS Study Investigators.

J Am Coll Cardiol. 2008 May 27;51(21):2034-9. doi: 10.1016/j.jacc.2008.01.053.


Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women.

Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB.

Arch Intern Med. 2008 Apr 14;168(7):713-20. doi: 10.1001/archinte.168.7.713. Erratum in: Arch Intern Med. 2008 Jun 23;168(12):1276.


Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study.

Glynn RJ, Buring JE, Manson JE, LaMotte F, Hennekens CH.

Arch Intern Med. 1994 Dec 12-26;154(23):2649-57.


Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial.

Silletta MG, Marfisi R, Levantesi G, Boccanelli A, Chieffo C, Franzosi M, Geraci E, Maggioni AP, Nicolosi G, Schweiger C, Tavazzi L, Tognoni G, Marchioli R; GISSI-Prevenzione Investigators.

Circulation. 2007 Dec 18;116(25):2944-51. Epub 2007 Dec 3.


Cardiovascular morbidity associated with nonadherence to statin therapy.

Blackburn DF, Dobson RT, Blackburn JL, Wilson TW.

Pharmacotherapy. 2005 Aug;25(8):1035-43.


Acute myocardial infarction in young adults: prognostic role of angiotensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphisms at medium-term follow-up.

Brscic E, Bergerone S, Gagnor A, Colajanni E, Matullo G, Scaglione L, Cassader M, Gaschino G, Di Leo M, Brusca A, Pagano GF, Piazza A, Trevi GP.

Am Heart J. 2000 Jun;139(6):979-84.


Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial.

Dagenais GR, Yi Q, Lonn E, Sleight P, Ostergren J, Yusuf S; HOPE Trial Investigators.

Eur J Cardiovasc Prev Rehabil. 2005 Feb;12(1):75-81.


Healthy lifestyle and the risk of stroke in women.

Kurth T, Moore SC, Gaziano JM, Kase CS, Stampfer MJ, Berger K, Buring JE.

Arch Intern Med. 2006 Jul 10;166(13):1403-9.


The rewards of good behavior.

Patel NB, Balady GJ.

Circulation. 2010 Feb 16;121(6):733-5. doi: 10.1161/CIR.0b013e3181d40d57. Epub 2010 Feb 1. No abstract available.


Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.

Reboldi G, Angeli F, Cavallini C, Gentile G, Mancia G, Verdecchia P.

J Hypertens. 2008 Jul;26(7):1282-9. doi: 10.1097/HJH.0b013e328306ebe2.


Role of cigarette smoking and gender in acute coronary syndrome events.

Howe M, Leidal A, Montgomery D, Jackson E.

Am J Cardiol. 2011 Nov 15;108(10):1382-6. doi: 10.1016/j.amjcard.2011.06.059. Epub 2011 Sep 15.


Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

APPRAISE Steering Committee and Investigators, Alexander JH, Becker RC, Bhatt DL, Cools F, Crea F, Dellborg M, Fox KA, Goodman SG, Harrington RA, Huber K, Husted S, Lewis BS, Lopez-Sendon J, Mohan P, Montalescot G, Ruda M, Ruzyllo W, Verheugt F, Wallentin L.

Circulation. 2009 Jun 9;119(22):2877-85. doi: 10.1161/CIRCULATIONAHA.108.832139. Epub 2009 May 26.


Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.

Corrao G, Conti V, Merlino L, Catapano AL, Mancia G.

Clin Ther. 2010 Feb;32(2):300-10. doi: 10.1016/j.clinthera.2010.02.004.


Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.

Teo KK, Sedlis SP, Boden WE, O'Rourke RA, Maron DJ, Hartigan PM, Dada M, Gupta V, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS; COURAGE Trial Investigators.

J Am Coll Cardiol. 2009 Sep 29;54(14):1303-8. doi: 10.1016/j.jacc.2009.07.013.

Items per page

Supplemental Content

Write to the Help Desk